1. Home
  2. KTTA vs MDRR Comparison

KTTA vs MDRR Comparison

Compare KTTA & MDRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

SELL

Current Price

$0.48

Market Cap

15.6M

Sector

Health Care

ML Signal

SELL

Logo Medalist Diversified REIT Inc.

MDRR

Medalist Diversified REIT Inc.

SELL

Current Price

$9.93

Market Cap

17.4M

Sector

Real Estate

ML Signal

SELL

Company Overview

Basic Information
Metric
KTTA
MDRR
Founded
2020
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
15.6M
17.4M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
KTTA
MDRR
Price
$0.48
$9.93
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 1.4M
6.8K
Earning Date
11-13-2026
11-13-2026
Dividend Yield
N/A
★ 2.73%
EPS Growth
★ 77.07
N/A
EPS
N/A
★ 8.79
Revenue
$486,559.00
★ $10,396,618.00
Revenue This Year
N/A
$0.91
Revenue Next Year
N/A
$1.70
P/E Ratio
★ N/A
$1.12
Revenue Growth
★ 3130.37
6.79
52 Week Low
$0.32
$9.46
52 Week High
$2.06
$14.52

Technical Indicators

Market Signals
Indicator
KTTA
MDRR
Relative Strength Index (RSI) 49.53 43.73
Support Level $0.42 $9.51
Resistance Level $0.57 $12.23
Average True Range (ATR) 0.08 0.97
MACD -0.00 -0.03
Stochastic Oscillator 48.59 20.53

Price Performance

Historical Comparison
KTTA
MDRR

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.

About MDRR Medalist Diversified REIT Inc.

Medalist Diversified Inc owns ten investment properties comprised of three retail properties, three flex/industrial properties, and four STNL properties, including the Tesla Pensacola Property. Through its subsidiary, the company sponsors Delaware Statutory Trusts (DSTs) that provide accredited investors access to institutional-quality real estate with the transparency and governance of a public company. The company has three reportable segments, consisting of retail center properties, flex center properties, and STNL properties. The company generates the majority of its revenue from the Retail Center Property.

Share on Social Networks: